Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Milton S. Hershey Medical Center
Milton S. Hershey Medical Center
National Cancer Institute (NCI)
Kura Oncology, Inc.
National Cancer Institute (NCI)
Kura Oncology, Inc.
Spanish Lung Cancer Group
Kura Oncology, Inc.
Kura Oncology, Inc.
Kura Oncology, Inc.
National Cancer Institute (NCI)
Kura Oncology, Inc.
Kura Oncology, Inc.
Samsung Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Abramson Cancer Center at Penn Medicine
National Cancer Institute (NCI)
University of Maryland, Baltimore
Abramson Cancer Center at Penn Medicine
National Cancer Institute (NCI)
Lymphoma Study Association
National Cancer Institute (NCI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
University Health Network, Toronto
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Emory University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fox Chase Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)